Novo Nordisk's Weight Loss Drug Ozempic Associated With Reduced Opioid, Alcohol Use Disorder Incidences, Study Shows

A recent real-world data analysis was conducted to suggest a link between glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 receptor agonists (GLP-1 RA) prescriptions and reduced rates of opioid overdose and alcohol intoxication among patients with opioid use disorder (OUD) and alcohol use disorder (AUD).

The study, which included over 500,000 OUD patients and more than 800,000 AUD patients, presents promising insights for novel treatment strategies in substance use disorders.

Also Read: Popular Ozempic May Have New Use As Semaglutide Drugs Linked To Reduced Overdose Risk In Diabetic Opioid Users.

The analysis revealed that patients with prescriptions for GIP ...